Skip to main content

Advertisement

SpringerLink
Log in

Atorvastatin-related rhabdomyolysis and acute renal failure in a genetically predisposed patient with potential drug–drug interaction

  • Case Report
  • Published:
International Journal of Clinical Pharmacy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. SEARCH Collaborative Group, Link E, Parish S, Armitage J, Bowman L, Heath S, Matsuda F, et al. SLCO1B1 variants and statin-induced myopathy–a genomewide study. N Engl J Med. 2008;359(8):789–99.

    Article  PubMed  CAS  Google Scholar 

  2. Hoenig MR, Walker PJ, Gurnsey C, Beadle K, Johnson L. The C3435T polymorphism in ABCB1 influences atorvastatin efficacy and muscle symptoms in a high-risk vascular cohort. J Clin Lipidol. 2011;5(2):91–6.

    Article  PubMed  Google Scholar 

  3. Bottorff MB. Statin safety and drug interactions: clinical implications. Am J Cardiol. 2006;97(8A):27C–31C.

    Article  PubMed  CAS  Google Scholar 

  4. Naranjo CA, Busto U, Seller EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239–45.

    Article  PubMed  CAS  Google Scholar 

  5. Meyer UA. Interaction of proton pump inhibitors with cytochromes P450: consequences for drug interactions. Yale J Biol Med. 1996;69(3):203–9.

    PubMed  CAS  Google Scholar 

  6. Zanger UM, Turpeinen M, Klein K, Schwab M. Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation. Anal Bioanal Chem. 2008;392(6):1093–108.

    Article  PubMed  CAS  Google Scholar 

  7. Desta Z, Zhao X, Shin JG, Flockhart DA. Clinical significance of the cytochrome P450 2C19 genetic polymorphism. Clin Pharmacokinet. 2002;41(12):913–58.

    Article  PubMed  CAS  Google Scholar 

  8. Li XQ, Andersson TB, Ahlström M, Weidolf L. Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities. Drug Metab Dispos. 2004;32(8):821–7.

    Article  PubMed  CAS  Google Scholar 

  9. Wilffert B, Swen J, Mulder H, Touw D. Maitland-Van der Zee AH, Deneer V; KNMP working group Pharmacogenetics. From evidence based medicine to mechanism based medicine. Reviewing the role of pharmacogenetics. Int J Clin Pharm. 2011;33(1):3–9.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We thank the employees of the Clinical Institute for Laboratory Diagnosis for their contribution to the manuscript.

Funding

None.

Conflicts of interest

None of the authors of this manuscript had any conflict of interests connected with the conduct of the study.

Author information

Authors and Affiliations

  1. Department of Clinical Pharmacology, University Hospital Dubrava, Av. Gojka Suska 6, 10000, Zagreb, Croatia

    Srecko Marusic & Ante Lisicic

  2. Department of Nephrology, University Hospital Dubrava, Av. Gojka Suska 6, 10000, Zagreb, Croatia

    Ivica Horvatic

  3. Department of Clinical Pharmacy, University Hospital Dubrava, Av. Gojka Suska 6, 10000, Zagreb, Croatia

    Vesna Bacic-Vrca

  4. Clinical Institute of Laboratory Diagnosis, University Hospital Center Zagreb, Kispaticeva 12, Zagreb, Croatia

    Nada Bozina

Authors
  1. Srecko Marusic
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ante Lisicic
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ivica Horvatic
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Vesna Bacic-Vrca
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Nada Bozina
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Srecko Marusic.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Marusic, S., Lisicic, A., Horvatic, I. et al. Atorvastatin-related rhabdomyolysis and acute renal failure in a genetically predisposed patient with potential drug–drug interaction. Int J Clin Pharm 34, 825–827 (2012). https://doi.org/10.1007/s11096-012-9717-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-012-9717-0

Keywords

Search

Navigation